Last reviewed · How we verify

NCT05882084

Oral Supplementation of Astaxanthin on Skin Photoaging, Hydration and Elasticity

Status unknown NA Last updated 25 July 2023
What this trial tests

NA trial testing Astaxanthin 6 mg daily in Photoaging in 24 participants. Status unknown.

Timeline
24 July 2023
Primary endpoint
30 September 2023
31 December 2023

Quick facts

Lead sponsorIntegrative Skin Science and Research
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment24
Start date24 July 2023
Primary completion30 September 2023
Estimated completion31 December 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Integrative Skin Science and Research

Who can join

Adults 30 to 55, female only, with Photoaging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a double-blind placebo controlled study to assess whether oral astaxanthin can improve skin hydration, skin elasticity, improve skin pigmentation, and reduce facial redness.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Photoaging

Currently open trials in the same condition.

Other Integrative Skin Science and Research trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05882084.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing